Partner Identification

Expanding Into Asia-Pacific: Life sciences opportunities and strategies for success
Objective :

Partners Identification for client’s early-stage oncology based clinical product for late-stage clinical development and commercialization.

Problem Statement:

A medium pharmaceutical client based in the US, with innovative formulations to treat Head and Neck Cancer, involved DelveInsight to identify a co-development partner, for the US and European region. The client was interested to involve a pharmaceutical company with experience around oncology, capabilities to develop the product through its clinical development cycle and also support commercial manufacturing for launching the product in the two regions.

Our Methodology:
  • Oncology Market Assessment
  • Assessment of Companies with Development and Commercialization Capabilities
  • Deal/Investment Assessment
  • Interest in Client’s candidate
  • 5-10 Potential Partners
Results:
  • Extensive Listing of Companies with requisite capabilities
  • Matrix Analysis of the top 25 companies researched.
  • The client could assess the Top 5-10 companies that fit their strategic needs and were interested in the partnership.
  • Final Engagement through DelveInsight to take the discussions forward.

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.